Preventing hepatitis B virus infection among healthcare professionals: potential impact of a 2-dose versus 3-dose vaccine

References

• World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B Infection. World Health Organization. [accessed 2020 December 23] https://apps.who.int/iris/bitstream/handle/10665/154590/9789241549059_eng.pdf;jsessionid=774FE3696FDF60D945FC39AAB691E916?sequence=1 .
   Google Scholar
• Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97–107. doi:10.1046/j.1365-2893.2003.00487.x.
   PubMed Web of Science ®Google Scholar
• Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55. doi:10.1016/S0140-6736(15)61412-X.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep. 2001;50(RR–11):1–52.
   Google Scholar
• Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention. Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(RR–7):1–45.
   Google Scholar
• Rosenberg JL, Jones DP, Lipitz LR, Kirsner JB. Viral hepatitis: an occupational hazard to surgeons. JAMA. 1973;223(4):395–400. doi:10.1001/jama.1973.03220040013003.
   PubMed Web of Science ®Google Scholar
• Trinkoff AM, Le R, Geiger-Brown J, Lipscomb J. Work schedule, needle use, and needlestick injuries among registered nurses. Infect Control Hosp Epidemiol. 2007;28(2):156–64. doi:10.1086/510785.
   PubMed Web of Science ®Google Scholar
• Sydnor E, Perl TM. Healthcare providers as sources of vaccine-preventable diseases. Vaccine. 2014;32(38):4814–22. doi:10.1016/j.vaccine.2014.03.097.
   PubMed Web of Science ®Google Scholar
• Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. Recommendations of the Advisory Committee on Immunization Practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR Morb Mortal Wkly Rep. 2018;67(15):455–58. doi:10.15585/mmwr.mm6715a5.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendation of the Immunization Practices Advisory Committee (ACIP). Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982;31(24):317–322, 327–318.
   Google Scholar
• Occupational Safety and Health Administration. OSHA’s bloodborne pathogens standard fact sheet. OSHA. [accessed 2020 June 11] https://www.osha.gov/OshDoc/data_BloodborneFacts/bbfact01.pdf .
   Google Scholar
• The National Surveillance System for Healthcare Workers (NaSH). Summary report for blood and body fluid exposure data collected from participating healthcare facilities (June 1995 through December 2007). CDC; 2011.
   Google Scholar
• Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep. 2013;128(6):498–509. doi:10.1177/003335491312800609.
   PubMed Web of Science ®Google Scholar
• Kuan RK, Janssen R, Heyward W, Bennett S, Nordyke R. Cost-effectiveness of hepatitis B vaccination using HEPLISAV in selected adult populations compared to Engerix-B® vaccine. Vaccine. 2013;31(37):4024–32. doi:10.1016/j.vaccine.2013.05.014.
   PubMed Web of Science ®Google Scholar
• Lu PJ, Euler GL. Influenza, hepatitis B, and tetanus vaccination coverage among health care personnel in the United States. Am J Infect Control. 2011;39(6):488–94. doi:10.1016/j.ajic.2010.10.009.
   PubMed Web of Science ®Google Scholar
• Williams WW, Lu PJ, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE, et al. Surveillance of vaccination coverage among adult populations - United States, 2015. MMWR Surveill Summ. 2017;66(11):1–28. doi:10.15585/mmwr.ss6611a1.
   PubMed Web of Science ®Google Scholar
• Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2018;67(1):1–31. doi:10.15585/mmwr.rr6701a1.
   PubMed Web of Science ®Google Scholar
• Kirkman-Liff B, Dandoy S. Cost of hepatitis B prevention in hospital employees: post-exposure prophylaxis. Infect Control. 1984;5(8):385–89. doi:10.1017/s0195941700062226.
   PubMedGoogle Scholar
• Hicks RA, Cullen JW, Jackson MA, Burry VF. Hepatitis B virus vaccine. Cost-benefit analysis of its use in a children’s hospital. Clin Pediatr (Phila). 1989;28(8):359–65. doi:10.1177/000992288902800805.
   PubMed Web of Science ®Google Scholar
• ENGERIX-B® (hepatitis B vaccine [recombinant]). Full Prescribing Information, GlaxoSmithKline Biologicals, 2019.
   Google Scholar
• RECOMBIVAX HB® (hepatitis B vaccine [recombinant]). Full Prescribing Information, Merck, Sharp & Dohme Corp. 2018.
   Google Scholar
• HEPLISAV-B® (hepatitis B vaccine [recombinant], adjuvanted). Full Prescribing Information, Dynavax Technologies Corporation, 2020.
   Google Scholar
• Heyward WL, Kyle M, Blumenau J, Davis M, Reisinger K, Kabongo ML, Bennett S, Janssen RS, Namini H, Martin JT. Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age. Vaccine. 2013;31(46):5300–05. doi:10.1016/j.vaccine.2013.05.068.
   PubMed Web of Science ®Google Scholar
• Halperin SA, Ward B, Cooper C, Predy G, Diaz-Mitoma F, Dionne M, Embree J, McGeer A, Zickler P, Moltz KH, et al. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age. Vaccine. 2012;30(15):2556–63. doi:10.1016/j.vaccine.2012.01.087.
   PubMed Web of Science ®Google Scholar
• Jackson S, Lentino J, Kopp J, Murray L, Ellison W, Rhee M, Shockey G, Akella L, Erby K, Heyward WL, et al. Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a Toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults. Vaccine. 2018;36(5):668–74. doi:10.1016/j.vaccine.2017.12.038.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. CDC Vaccine Price List. [accessed 2021 April 1] https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/ .
   Google Scholar
• Coates T, Wilson R, Patrick G, Andre F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther. 2001;23(3):392–403. doi:10.1016/s0149-2918(01)80044-8.
   PubMed Web of Science ®Google Scholar
• NSI Nursing Solutions Inc. 2020 NSI national health care retention & RN staffing report. [accessed 2020 June 11] https://www.nsinursingsolutions.com/Documents/Library/NSI_National_Health_Care_Retention_Report.pdf.
   Google Scholar
• Leigh JP, Gillen M, Franks P, Sutherland S, Nguyen HH, Steenland K, Xing G. Costs of needlestick injuries and subsequent hepatitis and HIV infection. Curr Med Res Opin. 2007;23(9):2093–105. doi:10.1185/030079907X219517.
   PubMed Web of Science ®Google Scholar
• Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol. 2017;31(3):239–47. doi:10.1016/j.bpg.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Doebbeling BN, Vaughn TE, McCoy KD, Beekmann SE, Woolson RF, Ferguson KJ, Torner JC. Percutaneous injury, blood exposure, and adherence to standard precautions: are hospital-based health care providers still at risk? Clin Infect Dis. 2003;37(8):1006–13. doi:10.1086/377535.
   PubMed Web of Science ®Google Scholar
• David C, Hirst A, Hyer R Consideration of effective seroprotection rate (eSPR) and cost per protected patient (CPP) as estimates of real-world outcomes in adult hepatitis B virus (HBV) vaccination. Paper presented at: National Foundation for Infectious Diseases 2020 Annual Conference on Vaccinology Research; 2020 March 23–25 [Virtual].
   Google Scholar
• Data on File. Dynavax Technologies, Emeryville (CA). 2020.
   Google Scholar
• Nelson JC, Bittner RC, Bounds L, Zhao S, Baggs J, Donahue JG, Hambidge SJ, Jacobsen SJ, Klein NP, Naleway AL, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009;99(suppl 2):S389–397. doi:10.2105/AJPH.2008.151332.
   PubMed Web of Science ®Google Scholar
• Truven Health Analytics. RED BOOK Online®. Micromedex healthcare series [database online]. [accessed 2020 January].
   Google Scholar
• Centers for Medicare & Medicaid Services. Medicare physician fee schedule. [accessed 2020 June 11] https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeeSched/PFS-National-Payment-Amount-File .
   Google Scholar
• Centers for Medicare & Medicaid Services. Medicare clinical laboratory fee schedule. [accessed 2020 June 11] https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ClinicalLabFeeSched/Clinical-Laboratory-Fee-Schedule-Files .
   Google Scholar
• Centers for Medicare & Medicaid Services. Medicare part B drug average sales price. [accessed 2020 June 11]. https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/2020-asp-drug-pricing-files.
   Google Scholar
• Centers for Disease Control and Prevention. Blood/body fluid exposure option. CDC. [accessed 2020 June 09]. https://www.cdc.gov/nhsn/pdfs/hps-manual/exposure/3-hps-exposure-options.pdf.
   Google Scholar
• US Department of Health and Human Services. Viral hepatitis in the United States: data and trends. [accessed 2020 October 16]. https://www.hhs.gov/hepatitis/learn-about-viral-hepatitis/data-and-trends/index.html .
   Google Scholar
• Gershon RR, Mitchell C, Sherman MF, Vlahov D, Lears MK, Felknor S, Lubelczyk RA. Hepatitis B vaccination in correctional health care workers. Am J Infect Control. 2005;33(9):510–18. doi:10.1016/j.ajic.2005.04.245.
   PubMed Web of Science ®Google Scholar
• Bick JA. Infection control in jails and prisons. Clin Infect Dis. 2007;45(8):1047–55. doi:10.1086/521910.
   PubMed Web of Science ®Google Scholar
• Frogner BK. The health care job engine: where do they come from and what do they say about our future? Med Care Res Rev. 2018;75(2):219–31. doi:10.1177/1077558716688156.
   PubMed Web of Science ®Google Scholar